Market Overview

TheStreet's Adam Feuerstein Tweets '$PTCT sets a very low bar for NICE reimbursement, helpful to $SRPT $BMRN if they can get their DMD drugs approved.'

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News

 

Related Articles (SRPT)